ALCAM has also previously been shown to be a key regulator of prostate cancer dissemination to, and tumor development within the bone, with ALCAM suppression reducing skeletal metastasis and intratibial tumor growth but having no proliferative effects on tumor development within an orthotopic model implanted into the prostate [6]. Here, ALCAM is linked to prostate cancer.